Illumina Ventures is a leading genomics and precision health investment firm based in San Francisco, CA. They are dedicated to building the ecosystem and driving innovation in the field of genomics, with a focus on accelerating advancements in human health. Illumina Ventures invests in companies that are developing novel analytical tools for structural biology, making single-cell sequencing more efficient, advancing cell-based therapeutics, and bringing gene editing approaches to patients with severe genetic diseases.
Through their portfolio companies, Illumina Ventures is at the forefront of revolutionizing the healthcare industry by tackling previously unsolvable problems and delivering life-changing therapies. Their investments aim to transform the way we understand complex biological processes, improve accessibility to cutting-edge technologies, and ultimately make a significant impact on human health.
Generated from the website